12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32426369 | XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer. | 2020 | 1 |
2 | 29117108 | Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells. | 2017 Nov 8 | 4 |
3 | 28149883 | Focusing the management of rectal cancer. | 2016 Dec | 1 |
4 | 23894404 | Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. | 2013 | 1 |
5 | 21167658 | X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients. | 2012 Jan 1 | 1 |
6 | 22580644 | Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population. | 2012 Jun | 1 |
7 | 23317245 | Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population. | 2012 | 2 |
8 | 21468552 | Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). | 2011 Mar-Apr | 1 |
9 | 21029695 | [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. | 2010 Jul | 1 |
10 | 17273745 | Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. | 2007 Mar | 2 |
11 | 17558308 | Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. | 2007 Jul | 2 |
12 | 11712813 | A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. | 2001 Jul-Aug | 1 |